Novo Nordisk A/S ADR (NY: NVO )

105.06 +2.43 (+2.37%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
April 14, 2008
Form 6-K
Source: SEC/Edgar
April 07, 2008
Form 6-K
Source: SEC/Edgar
April 01, 2008
Form 6-K
Source: SEC/Edgar
April 01, 2008
Form 6-K
Source: SEC/Edgar
April 01, 2008
Form 6-K
Source: SEC/Edgar
March 31, 2008
Form 6-K
Source: SEC/Edgar
March 18, 2008
Form 6-K
Source: SEC/Edgar
March 12, 2008
Form 6-K
Source: SEC/Edgar
March 10, 2008
Form 6-K
Source: SEC/Edgar
March 04, 2008
Form 6-K
Source: SEC/Edgar
February 25, 2008
Form 6-K
Source: SEC/Edgar
February 20, 2008
Form 6-K
Source: SEC/Edgar
February 18, 2008
Form 6-K
Source: SEC/Edgar
February 13, 2008
Form SC 13G/A
Source: SEC/Edgar
February 12, 2008
Form 6-K
Source: SEC/Edgar
February 11, 2008
Form 6-K
Source: SEC/Edgar
February 11, 2008
Form 6-K
Source: SEC/Edgar
February 10, 2008
Form SC 13G
Source: SEC/Edgar
February 10, 2008
Form SC 13G
Source: SEC/Edgar
February 10, 2008
Form 6-K
Source: SEC/Edgar
February 10, 2008
Form 20-F
Source: SEC/Edgar
February 10, 2008
Form 6-K
Source: SEC/Edgar
February 05, 2008
Form 6-K
Source: SEC/Edgar
February 05, 2008
Form 6-K
Source: SEC/Edgar
February 04, 2008
Form 6-K
Source: SEC/Edgar
February 04, 2008
Form 6-K
Source: SEC/Edgar
January 15, 2008
Form 6-K
Source: SEC/Edgar
January 02, 2008
Form 6-K
Source: SEC/Edgar
December 12, 2007
Form 6-K
Source: SEC/Edgar
December 11, 2007
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.